13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Perceptive Advisors Joseph Edelman | 9,383,456 | $42,319,387 | 1.49% | |
2. | Suvretta Capital Management Aaron Cowen | 9,135,029 | $41,198,981 | +81% | 1.53% |
3. | Baker Bros. Advisors Julian Baker And Felix Baker | 7,275,830 | $32,813,993 | 0.36% | |
4. | Vestal Point Capital Ryan Wilder | 7,192,700 | $32,439,077 | +15% | 2.32% |
5. | OrbiMed Advisors Samuel Isaly | 3,087,462 | $13,924,454 | 0.33% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 8,583,568 | $38,711,892 | 0.01% | |
2. | 6,909,510 | $31,161,890 | 0.48% | |
3. | 3,093,614 | $13,952,199 | 0% | |
4. | 2,973,032 | $13,408,374 | 0.03% | |
5. | 1,987,292 | $8,962,687 | 0% |